Trial Profile
A Phase I Trial of Irinotecan, Radiation Therapy and Escalating Doses of Docetaxel With Cisplatin in Locally Advanced Esophageal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 01 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Dec 2006 New trial record.